
In the sixth part of the series, students discussed how their involvement in pandemic-related vaccinations or aid efforts affected how they viewed the field and their role in the field.
In the sixth part of the series, students discussed how their involvement in pandemic-related vaccinations or aid efforts affected how they viewed the field and their role in the field.
Panelists provide tips on how pharmacists can encourage their patients to get their COVID-19 and influenza vaccines this year.
English discussed the challenges and highlights of her time in the trial, in addition to what she feels health care professionals should learn from her own treatment experience.
Dennis Wright, senior director of product marketing for Central Pharmacy Compounding and Dispensing at Omnicell, discusses methods of addressing the rising rate of hospital pharmacist burnout through automation and technology-enabled services.
In the fifth part of the series, students discussed the effects the pandemic had on their future career goals or prospects.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
A discussion on the COVID-19 pandemic’s impact on pharmacy staff and solutions to help combat pharmacy staff fatigue, burnout, and vaccine hesitancy.
Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, addresses how the role of pharmacists, opportunities, and issues facing community pharmacies internationally compare to the experience of community pharmacists in the United States.
Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the FDA’s new guidance Project Optimus, which addresses issues relating to dose optimization in clinical trials assessing oncology drugs.
Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) was approved in July in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma following their first or subsequent relapse.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.
Nicholas Mathews, co-founder of Stillwater Behavioral Health, discusses how pharmacists can respond to the identification of potentially problematic opioid prescription practices at sober-living facilities.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.
Lisa M. Nijm, MD, JD, educates on Eysuvis, an FDA-approved prescription therapeutic for dry eye disease.
John Beckner, RPh, discusses some of the obstacles to achieving herd immunity for COVID-19.
Antonio Ciaccia, CEO of 46brooklyn Research, discusses his company’s efforts to uncover and understand the structure that underlies US drug pricing distortions.
Sharon Park, PharmD, MEd, BCPS, , associate professor and assistant dean for academic affairs at the Notre Dame of Maryland University School of Pharmacy, discusses career options for pharmacy students outside of the traditional roles of a pharmacist.
Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, assistant professor of pharmacy practice at Loma Linda University School of Pharmacy, discusses the importance of Black pharmacists in creating equitable access to COVID-19 vaccinations.
Experts share final thoughts and advice for clinicians in the community to help optimize treatment success in CLL.
A panel of key stakeholders in the pharmacy field discuss the nature of environmental conditions as a social determinant of health and the potential impact on patient health outcomes, as well as how to best educate patients and colleagues when approaching the subject in the pharmacy.
Octagam 10% is indicated for the treatment of chronic immune thrombocytopenic purpura in adults and dermatomyositis (DM) in adults
The panel discusses the possible prescription treatments for dry eye disease.
With consideration of recent COVID-19 vaccine approval in adolescents, Jennifer Adams, PharmD, EdD, discusses pharmacy’s role in immunizing children of all ages.
The new format being rolled out at Rite Aid stores is designed to center pharmacists and make them easily accessible to patients.
Emerging combination therapies and novel agents being studied as initial therapy for CLL are discussed.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.
In The Legal Prescription series with Ned Milenkovich, we discuss a set of important topics in the pharmacy landscape.
A panel of pharmacists and doctors explain when a patient should seek professional help for dry eye disease.
Study examines whether dapagliflozin is cost-effective when added to standard of care for patients who have heart failure with reduced ejection fraction.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.